Abstract
A retrospective chart review was performed of all patients with juvenile idiopathic arthritis (JIA) followed at our clinic who had an intra-articular steroid injection between 1 January 1997 and 31 December 2001. The aim of the study was to evaluate the outcome of intra-articular steroid injections (iaS) and determine prognostic factors. During the study period, 202 iaS were performed in 60 patients, of whom 37 had oligoarticular JIA, 15 had polyarticular, rheumatoid factor-negative JIA and four each had systemic and enthesitis-related JIA. The median duration of remission was 23.1 months (range: 0–69 months). At last follow-up, 103 joints (51%) of 47 patients were still in remission after a median follow-up time of 28 months (range: 1–69 months). For the total cohort, the remission was longer for wrist and finger joints [risk ratio (RR): 0.2], with concomitant treatment with methotrexate (RR: 0.28) and for enthesitis-related arthritis (RR: 0.34). For the group of knee joints, remission was longer with concomitant treatment with methotrexate (RR: 0.37), with triamcinolone hexacetonide (RR: 0.77) and with general anaesthesia for the procedure (RR: 0.56). Mild side effects were observed in 45 iaS (22.3%), and skin atrophy occurred at the injection site in 2% of injections, but no major adverse event occurred in our cohort. In conclusion, iaS is a safe procedure with a median duration of remission of 23.1 months. The remission was longer in the joints of the upper extremity, with concomitant treatment with methotrexate and when the injection was performed under general anaesthesia.
Similar content being viewed by others
Abbreviations
- ANA:
-
anti-nuclear antibody
- HLA B27:
-
human leucocyte antigen B27
- iaS:
-
intra-articular steroid injection
- JIA:
-
juvenile idiopathic arthritis
- NSAR:
-
non-steroidal anti-rheumatic drugs
- RR:
-
risk ratio
- TNFα:
-
tumour necrosis factor alpha
References
Allen RC, Gross KR, Laxer RM, Malleson PN, Beauchamp RD, Petty RE (1986) Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children. Arthritis Rheum 29:997–1001
Breit W, Frosch M, Meyer U, Heinecke A, Ganser G (2000) A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J Rheumatol 27:2696–2702
Chakravarty K, Pharoah PD, Scott DG (1994) A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis. Br J Rheumatol 33:464–468
Cron RQ, Sharma S, Sherry DD (1999) Current treatment by United States and Canadian pediatric rheumatologists. J Rheumatol 26:2036–2038
Eberhard BA, Sison MC, Gottlieb BS, Ilowite NT (2004) Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 31:2507–2512
Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID (2003) Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum 48:767–775
Ilowite NT (2002) Current treatment of juvenile rheumatoid arthritis. Pediatrics 109:109–115
Job-Deslandre C, Menkes CJ (1990) Complications of intra-articular injections of triamcinolone hexacetonide in chronic arthritis in children. Clin Exp Rheumatol 8:413–416
Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ (2003) Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 48:218–226
Manners PJ, Bower C (2002) Worldwide prevalence of juvenile arthritis why does it vary so much? J Rheumatol 29:1520–1530
Narayanan K, Rajendran CP, Porkodi R, Shanmuganandan K (2002) A follow-up study of juvenile rheumatoid arthritis into adulthood. J Assoc Physicians India 50:1039–1041
Neidel J, Boehnke M, Kuster RM (2002) The efficacy and safety of intraarticular corticosteroid therapy for coxitis in juvenile rheumatoid arthritis. Arthritis Rheum 46:1620–1628
Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M (2002) Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 29:1989–1999
Padeh S, Passwell JH (1998) Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 41:1210–1214
Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25:1991–1994
Ravelli A, Manzoni SM, Viola S, Pistorio A, Ruperto N, Martini A (2001) Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis. J Rheumatol 28:2100–2102
Sandorfi N, Freundlich B (1997) Psoriatic and seronegative inflammatory arthropathy associated with a traumatic onset: 4 cases and a review of the literature. J Rheumatol 24:187–192
Schneider R, Passo MH (2002) Juvenile rheumatoid arthritis. Rheum Dis Clin North Am 28:503–530
Sherry DD, Stein LD, Reed AM, Schanberg LE, Kredich DW (1999) Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum 42:2330–2334
Wallace DJ (1994) Does stress or trauma cause or aggravate rheumatic disease? Baillieres Clin Rheumatol 8:149–159
Weitoft T, Ronnblom L (2003) Randomised controlled study of postinjection immobilisation after intra-articular glucocorticoid treatment for wrist synovitis. Ann Rheum Dis 62:1013–1015
Weitoft T, Larsson A, Saxne T, Ronnblom L (2005) Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis. Ann Rheum Dis 64:1750–1753
Zulian F, Martini G, Gobber D, Plebani M, Zacchello F, Manners P (2004) Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology 43:1288–1291
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marti, P., Molinari, L., Bolt, I.B. et al. Factors Influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis. Eur J Pediatr 167, 425–430 (2008). https://doi.org/10.1007/s00431-007-0525-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-007-0525-9